Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation.

[1]  U. Bayraktar,et al.  Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. , 2010, World journal of gastroenterology.

[2]  Shaohua Chen,et al.  Clonal expanded TRA and TRB subfamily T cells in peripheral blood from patients with diffuse large B-cell lymphoma , 2010, Hematology.

[3]  Wang-jun Liao,et al.  Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin , 2010, Cancer Immunology, Immunotherapy.

[4]  L. Dai,et al.  Evaluation of Tumour‐Associated Antigen (TAA) Miniarray in Immunodiagnosis of Colon Cancer , 2009, Scandinavian journal of immunology.

[5]  W. Luo,et al.  Analysis of the interindividual conservation of T cell receptor α‐ and β‐chain variable regions gene in the peripheral blood of patients with systemic lupus erythematosus , 2008, Clinical and experimental immunology.

[6]  T. Randall,et al.  Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus , 2008, The Journal of experimental medicine.

[7]  A. Rughetti,et al.  Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors. , 2007, European journal of cancer.

[8]  T. Ichim,et al.  Stem Cell Therapy for Autism , 2007, Journal of Translational Medicine.

[9]  Maximilian Waldner,et al.  Colon cancer and the immune system: the role of tumor invading T cells. , 2006, World journal of gastroenterology.

[10]  A. Österborg,et al.  Reconstitution of the T‐cell repertoire following treatment with alemtuzumab (anti‐CD52 monoclonal antibody) in patients with B‐cell chronic lymphocytic leukaemia , 2006, British journal of haematology.

[11]  S. Verjovski-Almeida,et al.  Auto‐antibodies in prostate cancer: Humoral immune response to antigenic determinants coded by the differentially expressed transcripts FLJ23438 and VAMP3 , 2006, The Prostate.

[12]  J. Fagerberg,et al.  T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody , 2005, Cancer Immunology, Immunotherapy.

[13]  J. Fagerberg,et al.  Vaccination with Ep-CAM Protein or Anti-Idiotypic Antibody Induces Th1-Biased Response against MHC Class I- and II-Restricted Ep-CAM Epitopes in Colorectal Carcinoma Patients , 2004, Clinical Cancer Research.

[14]  A. Zbar.  The immunology of colorectal cancer. , 2004, Surgical oncology.

[15]  T. Ochi,et al.  Evidence for existence of oligoclonal tumor-infiltrating lymphocytes and predominant production of T helper 1/T cytotoxic 1 type cytokines in gastric and colorectal tumors. , 2004, International journal of oncology.

[16]  R. Rees,et al.  Trafficking of tumor peptide‐specific cytotoxic T lymphocytes into the tumor microcirculation , 2004, International journal of cancer.

[17]  I. Messaoudi,et al.  The many important facets of T-cell repertoire diversity , 2004, Nature Reviews Immunology.

[18]  J. Ritz,et al.  Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion. , 2003, Cancer research.

[19]  Y. Iwakura,et al.  IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[21]  M. T. Moser,et al.  T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  F. Mami-Chouaib,et al.  Analysis of T‐cell‐receptor β‐chain‐gene usage in peripheral‐blood and tumor‐infiltrating lymphocytes from human non‐small‐cell lung carcinomas , 1999 .

[23]  I. Arany,et al.  Tumor differentiation-dependent local immunity in human head and neck cancers. , 1998, Cancer letters.

[24]  A. Vallejo.  Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged , 2006, Immunologic research.

[25]  D. Neuberg,et al.  Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. , 2000, Blood.

[26]  F. Mami-Chouaib,et al.  Analysis of T-cell-receptor beta-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas. , 1999, International journal of cancer.